ポンペ病の世界市場レポート 2024

ポンペ病の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.3%の年間複合成長率（CAGR）で21億3,000万米ドルに成長すると予想されます。予測期間に予想される成長は、進行中の研究開発、新生児スクリーニングプログラムの延長、遺伝子治療の進歩、希少疾患への世界の投資の増加、患者中心の医薬品開発への注力、臨床検査の拡大によるものと考えられます。治験と調査の取り組み、および市場における個別化医療アプローチの重視。予測期間中に予想される主な動向には、製品革新、技術進歩、患者サポートプログラムの実施、患者管理のための遠隔医療の採用増加、アクセスプログラムの拡大に向けた協力的な取り組みなどが含まれます。

ポンペ病の普及率の上昇により、ポンペ病市場の成長が促進されると予想されます。グリコーゲン貯蔵疾患II型または酸性マルターゼ欠損症としても知られるこの希少な遺伝性疾患は、さまざまな体の組織、特に筋肉や臓器に複雑な糖分子であるグリコーゲンが蓄積することを特徴としています。 ポンペ病の治療法には、タンパク質補充療法、アルグルコシダーゼアルファ、ネクスビアザイム点滴静注などが含まれます。 2022年 6月に欧州医薬品庁ハイライトで報告されたようなポンペ病症例の増加は、ポンペ病市場の拡大に寄与すると予想されます。欧州だけでも、ポンペ病の原因となる可能性のある突然変異を持つ乳児発症者が約224人、若年発症者が471人、成人発症者が20,490人います。

ポンペ病市場も、ヘルスケアの高騰により大幅な成長を遂げています。政府や保険会社は、革新的な治療法へのアクセスを確保することの重要性をますます認識しています。 2023年6月のメディケア・メディケイド・サービスセンター（CMS）のデータによると、米国の国民医療費（NHE）は2021年に4兆3,000億米ドルに達し、2.7％増加し、国内総生産の18.3％を占めた（ GDP）。このヘルスケア支出の増加により、ポンペ病市場が前進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のポンペ病市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 古典的乳児型
• 非古典的乳児型
• 遅発型
• その他のタイプ
• 世界のポンペ病市場、診断別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 血液検査
• 遺伝子検査
• 出生前検査
• その他の診断
• 世界のポンペ病市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 非経口
• その他の投与経路
• 世界のポンペ病市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 酵素補充療法（ERT）
• 基質除去療法（SRT）
• 遺伝子治療
• その他の治療
• 世界のポンペ病市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院または診療所
• 医薬品
• 研究者
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のポンペ病市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のポンペ病市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ポンペ病市場の競合情勢
• ポンペ病市場の企業プロファイル
  • F. Hoffmann-La Roche AG
  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Thermo Fisher Scientific Inc.

第31章 その他の大手および革新的な企業

• Fresenius Kabi AG
• Danaher Corporation
• Becton, Dickinson and Company
• Astellas Pharma Inc.
• BioMerieux SA
• BioMarin Pharmaceutical Inc.
• Nova Biomedical Corporation
• Instrumentation Laboratory Company
• Amicus Therapeutics Inc.
• Sekisui Diagnostics LLC
• Spark Therapeutics Inc.
• Sangamo BioSciences Inc.
• Asklepios BioPharmaceutical Inc.
• Avrobio Inc.
• EKF Diagnostics Holdings plc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Pompe disease is a genetic disorder characterized by the accumulation of a complex sugar known as glycogen within the cells of the body. This condition arises due to a deficiency in the enzyme acid alfa glucosidase (GAA), responsible for breaking down complex carbohydrates in the body.

Pompe disease manifests in several forms, including the classic infantile form, non-classic infantile form, late-onset form, and others. The classic infantile form is the most widely recognized, presenting significant heart dysfunction and noticeable hypotonia within a few months of birth. Diagnosis involves various methods such as blood tests, genetic tests, prenatal tests, and others. Treatment options for Pompe disease encompass oral, parenteral, and alternative approaches. Therapies include enzyme replacement therapy (ERT), substrate reduction therapy (SRT), gene therapy, and other modalities utilized by hospitals, clinics, pharmaceuticals, researchers, and other stakeholders.

The pompe disease market research report is one of a series of new reports from The Business Research Company that provides pompe disease market statistics, including pompe disease industry global market size, regional shares, competitors with a pompe disease market share, detailed pompe disease market segments, market trends and opportunities, and any further data you may need to thrive in the pompe disease industry. This pompe disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pompe disease market size has grown steadily in recent years. It will grow from $1.66 billion in 2023 to $1.73 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The expansion observed in the historical period can be ascribed to heightened awareness and diagnosis, the designation of orphan drugs and associated incentives, worldwide collaborations and research initiatives, as well as the active involvement of patient advocacy and support groups.

The pompe disease market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be credited to ongoing research and development, the extension of newborn screening programs, progress in gene therapy, a rise in global investment in rare diseases, a focus on patient-centric drug development, the enlargement of clinical trials and research initiatives, and an emphasis on personalized medicine approaches within the market. Key trends expected in the forecast period encompass product innovation, technological advancements, the execution of patient support programs, an increasing adoption of telemedicine for patient management, and collaborative efforts for expanded access programs.

The rising prevalence of Pompe disease is anticipated to drive the growth of the Pompe disease market. Also known as glycogen storage disease type II or acid maltase deficiency, this rare genetic disorder is characterized by the accumulation of glycogen, a complex sugar molecule, in various body tissues, particularly in muscles and organs. Treatments for Pompe disease include protein replacement therapy, alglucosidase alfa, and Nexviazyme for intravenous infusion. The increase in Pompe disease cases, such as those reported by the European Medicines Agency Highlights in June 2022, is expected to contribute to the expansion of the Pompe disease market. In Europe alone, there are approximately 224 infantile-onset, 471 juvenile-onset, and 20,490 adult-onset individuals with mutations potentially causing Pompe disease.

The Pompe disease market is also experiencing significant growth due to the escalating healthcare expenditure. Governments and insurance providers increasingly recognize the importance of ensuring access to innovative therapies. According to data from the Centers for Medicare & Medicaid Services (CMS) in June 2023, the national health expenditure (NHE) in the United States reached $4.3 trillion in 2021, growing by 2.7% and accounting for 18.3% of the Gross Domestic Product (GDP). This rise in healthcare expenditure is expected to drive the Pompe disease market forward.

Product innovations are a prominent trend in the Pompe disease market, with major companies adopting innovations to maintain their market position. For example, in September 2023, Amicus Therapeutics received approval from the U.S. Food and Drug Administration (FDA) for Pombiliti and Opfolda, a two-component therapy designed for adults with late-onset Pompe disease. The therapy combines a recombinant human GAA enzyme (rhGAA) for increased uptake into muscle cells with an enzyme stabilizer (Opfolda) to stabilize the enzyme in the blood. This FDA approval highlights the importance of advancements in science and medicine.

Major companies in the Pompe disease market are focused on developing therapies such as enzyme replacement therapy (ERT) for the treatment of late-onset Pompe disease, addressing severe symptoms such as respiratory disorders and muscle failure. For instance, in August 2021, Sanofi received approval from the European Commission for Nexviazyme, an enzyme replacement treatment (ERT) targeting the mannose-6-phosphate (M6P) receptor, a primary mechanism for cellular uptake in Pompe disease. Clinical trials have shown that Nexviazyme increases respiratory function and walking distance in patients.

In January 2022, Hansa Biopharma AB and Asklepios BioPharmaceutical Inc. collaborated to assess the potential use of imlifidase as a pre-treatment before administering AskBio's gene therapy for Pompe disease. This partnership involves a pre-clinical and clinical feasibility program for patients with pre-existing neutralizing antibodies to adeno-associated virus (AAV). Hansa will receive a $5 million payment, and AskBio holds an exclusive option for a full development and commercialization agreement based on the results of an initial Phase I/II study. AskBio will lead the pre-clinical and clinical studies, while Hansa will provide materials and additional support outlined in the feasibility program.

Major companies operating in the pompe disease market report are F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Fresenius Kabi AG, Danaher Corporation, Becton, Dickinson and Company, Astellas Pharma Inc., BioMerieux SA, BioMarin Pharmaceutical Inc., Nova Biomedical Corporation, Instrumentation Laboratory Company, Amicus Therapeutics Inc., Sekisui Diagnostics LLC, Spark Therapeutics Inc., Sangamo BioSciences Inc., Asklepios BioPharmaceutical Inc., Avrobio Inc., EKF Diagnostics Holdings PLC, Trinity Biotech PLC, Chembio Diagnostics Inc., Audentes Therapeutics Inc., Rougine Darou, Genethon, Maze Therapeutics Inc., Avidity Biosciences Inc., EpiVax Inc., M6P Therapeutics, Oxyrane UK Limited, Valerion Therapeutics LLC

North America was the largest region in the pompe disease market in 2023. The regions covered in the pompe disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pompe disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pompe disease market includes revenues earned by entities by lumizyme, alglucosidase alfa, nexviazyme, and aval glucosidase alfa. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pompe Disease Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pompe disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pompe disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pompe disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Classic Infantile Form; Non-Classic Infantile Form; Late-Onset Form; Other Types
• 2) By Diagnosis: Blood Test; Genetic Test; Prenatal Test; Other Diagnosis
• 3) By Route of Administration: Oral; Parenteral; Other routes of administrations
• 4) By Therapy Type: Enzyme Replacement Therapy (ERT); Substrate Reduction Therapy (SRT); Gene Therapy; Other Therapies
• 5) By End Users: Hospitals / Clinics; Pharmaceuticals; Researchers; Other End-Users
• Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Novartis AG; Sanofi S.A.; Thermo Fisher Scientific Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pompe Disease Market Characteristics

3. Pompe Disease Market Trends And Strategies

4. Pompe Disease Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Pompe Disease Market Size and Growth

• 5.1. Global Pompe Disease Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pompe Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pompe Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pompe Disease Market Segmentation

• 6.1. Global Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Classic Infantile Form
• Non-Classic Infantile Form
• Late-Onset Form
• Other Types
• 6.2. Global Pompe Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Blood Test
• Genetic Test
• Prenatal Test
• Other Diagnoses
• 6.3. Global Pompe Disease Market, Segmentation By Routes of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Other routes of administration
• 6.4. Global Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Enzyme Replacement Therapy (ERT)
• Substrate Reduction Therapy (SRT)
• Gene Therapy
• Other Therapies
• 6.5. Global Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals or Clinics
• Pharmaceuticals
• Researchers
• Other End-Users

7. Pompe Disease Market Regional And Country Analysis

• 7.1. Global Pompe Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pompe Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pompe Disease Market

• 8.1. Asia-Pacific Pompe Disease Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pompe Disease Market

• 9.1. China Pompe Disease Market Overview
• 9.2. China Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pompe Disease Market

• 10.1. India Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pompe Disease Market

• 11.1. Japan Pompe Disease Market Overview
• 11.2. Japan Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pompe Disease Market

• 12.1. Australia Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pompe Disease Market

• 13.1. Indonesia Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pompe Disease Market

• 14.1. South Korea Pompe Disease Market Overview
• 14.2. South Korea Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pompe Disease Market

• 15.1. Western Europe Pompe Disease Market Overview
• 15.2. Western Europe Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pompe Disease Market

• 16.1. UK Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pompe Disease Market

• 17.1. Germany Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pompe Disease Market

• 18.1. France Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pompe Disease Market

• 19.1. Italy Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pompe Disease Market

• 20.1. Spain Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pompe Disease Market

• 21.1. Eastern Europe Pompe Disease Market Overview
• 21.2. Eastern Europe Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pompe Disease Market

• 22.1. Russia Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pompe Disease Market

• 23.1. North America Pompe Disease Market Overview
• 23.2. North America Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pompe Disease Market

• 24.1. USA Pompe Disease Market Overview
• 24.2. USA Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pompe Disease Market

• 25.1. Canada Pompe Disease Market Overview
• 25.2. Canada Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pompe Disease Market

• 26.1. South America Pompe Disease Market Overview
• 26.2. South America Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pompe Disease Market

• 27.1. Brazil Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pompe Disease Market

• 28.1. Middle East Pompe Disease Market Overview
• 28.2. Middle East Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pompe Disease Market

• 29.1. Africa Pompe Disease Market Overview
• 29.2. Africa Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pompe Disease Market Competitive Landscape And Company Profiles

• 30.1. Pompe Disease Market Competitive Landscape
• 30.2. Pompe Disease Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Novartis AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sanofi S.A.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Thermo Fisher Scientific Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Pompe Disease Market Other Major And Innovative Companies

• 31.1. Fresenius Kabi AG
• 31.2. Danaher Corporation
• 31.3. Becton, Dickinson and Company
• 31.4. Astellas Pharma Inc.
• 31.5. BioMerieux SA
• 31.6. BioMarin Pharmaceutical Inc.
• 31.7. Nova Biomedical Corporation
• 31.8. Instrumentation Laboratory Company
• 31.9. Amicus Therapeutics Inc.
• 31.10. Sekisui Diagnostics LLC
• 31.11. Spark Therapeutics Inc.
• 31.12. Sangamo BioSciences Inc.
• 31.13. Asklepios BioPharmaceutical Inc.
• 31.14. Avrobio Inc.
• 31.15. EKF Diagnostics Holdings plc

32. Global Pompe Disease Market Competitive Benchmarking

33. Global Pompe Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pompe Disease Market

35. Pompe Disease Market Future Outlook and Potential Analysis

• 35.1 Pompe Disease Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Pompe Disease Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Pompe Disease Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer